Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
Lao PDR

Global PrEP Tracker
Last Updated: 19 November 2024

Drug Registration Status

Approved
Not
Approved
Under
Review
Data not
available
Gilead's Truvada (TDF/xTC*) Registration
Approved N/A N/A
Generic versions of TDF/xTC* for prevention
Not Approved
ViiV's Apretude (CAB for PrEP) Registration
Not Approved
IPM's Dapivirine Vaginal Ring Registration
Not Approved
Oral F/TAF (Descovy) Registration
Not Approved
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

1 Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

N/A Planned/Ongoing Projects

Est. Cumulative
Initiations:

Total PrEP: 1,740

Oral PrEP: 1,740

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

Where To Access PrEP in Lao PDR:

PrEPMap

Featured Resources

Document

Asia Region ROP, 2022

The goal of 2022 Regional Operational Plan for the Asia Region is to maintain progress from 2021 in key areas related to health promotion such as refining efforts to eliminate policy barriers, insitutionalizing client- centered services, helping the countries under PEPFAR in the Asia Region achieve 95-95-95, and spotlighting HIV prevention and treatment access for…
View All Resources